Literature DB >> 12769404

Topical therapy for actinic keratoses, II: Diclofenac, colchicine, and retinoids.

William D Tutrone1, Ritu Saini, Selin Caglar, Jeffrey M Weinberg, Jorge Crespo.   

Abstract

Actinic keratoses (AKs) are evolving, malignant cutaneous neoplasms. AKs can be treated with physical or destructive methods and by topical therapies. This article is the second in a 2-part series of current topical therapeutic options for AKs and discusses topical diclofenac, colchicine, and retinoids. The first part focused on topical 5-fluorouracil and imiquimod.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12769404

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  5 in total

Review 1.  Understanding the molecular mechanisms of cancer prevention by dietary phytochemicals: From experimental models to clinical trials.

Authors:  Girish B Maru; Rasika R Hudlikar; Gaurav Kumar; Khushboo Gandhi; Manoj B Mahimkar
Journal:  World J Biol Chem       Date:  2016-02-26

2.  Comparative study of actinic keratosis treatment with 3% diclofenac sodium and 5% 5-fluorouracil.

Authors:  Majoriê Mergen Segatto; Sérgio Ivan Torres Dornelles; Vera Bauer Silveira; Gabriela de Oliveira Frantz
Journal:  An Bras Dermatol       Date:  2013 Sep-Oct       Impact factor: 1.896

Review 3.  Patient satisfaction and reported outcomes on the management of actinic keratosis.

Authors:  Raveena Khanna; Anshika Bakshi; Yasmin Amir; Gary Goldenberg
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-05-17

Review 4.  Colchicine in Managing Skin Conditions: A Systematic Review.

Authors:  Stefano Dastoli; Steven Paul Nisticò; Pietro Morrone; Cataldo Patruno; Antonio Leo; Rita Citraro; Luca Gallelli; Emilio Russo; Giovambattista De Sarro; Luigi Bennardo
Journal:  Pharmaceutics       Date:  2022-01-27       Impact factor: 6.321

5.  Topical Colchicine Gel versus Diclofenac Sodium Gel for the Treatment of Actinic Keratoses: A Randomized, Double-Blind Study.

Authors:  Gita Faghihi; Azam Elahipoor; Fariba Iraji; Shadi Behfar; Bahareh Abtahi-Naeini
Journal:  Adv Med       Date:  2016-09-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.